ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,217,000 | +66.4% | 117,542 | +3.9% | 0.00% | +100.0% |
| Q2 2019 | $1,332,000 | -13.7% | 113,142 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $1,544,000 | +37.4% | 113,142 | +3.2% | 0.00% | +100.0% |
| Q4 2018 | $1,124,000 | -38.4% | 109,642 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $1,826,000 | +5.4% | 109,642 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,732,000 | +24.4% | 109,642 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $1,392,000 | +10.9% | 109,642 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $1,255,000 | +5.3% | 109,642 | +12.6% | 0.00% | 0.0% |
| Q3 2017 | $1,192,000 | +56.8% | 97,342 | +46.7% | 0.00% | 0.0% |
| Q2 2017 | $760,000 | -44.9% | 66,342 | 0.0% | 0.00% | -50.0% |
| Q1 2017 | $1,380,000 | +2.6% | 66,342 | +2.6% | 0.00% | 0.0% |
| Q4 2016 | $1,345,000 | -36.5% | 64,642 | 0.0% | 0.00% | -33.3% |
| Q3 2016 | $2,118,000 | +33.5% | 64,642 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $1,587,000 | +82.8% | 63,542 | +72.7% | 0.00% | +50.0% |
| Q1 2016 | $868,000 | -6.8% | 36,800 | +30.5% | 0.00% | 0.0% |
| Q4 2015 | $931,000 | +0.8% | 28,200 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $924,000 | -28.2% | 28,200 | +16.0% | 0.00% | -33.3% |
| Q2 2015 | $1,287,000 | – | 24,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |